Skip to main content
. 2020 Mar 5;11(3):172. doi: 10.1038/s41419-020-2359-6

Fig. 4. Effects of BMP4 on the therapeutic efficacy of BMMSCs in SS.

Fig. 4

a, b BMP4 mRNA and protein levels in bone marrow-derived mesenchymal stem cells (BMMSCs) derived from NOD/ShiLtJ and ICR mice. c, d Prostaglandin E2 (PGE2) levels in supernatant of BMMSCs and submandibular glands from NOD/ShiLtJ and ICR mice. e The saliva flow rate of WT mice BMMSCs-treated mice was significantly blocked with BMP4 inhibition. f, g H&E staining showed that the area of infiltrating in the submandibular glands of NOD/ShiLtJ mice following BMMSCs injection was significantly smaller than untreated NOD/Ltj mice, and this protective effect was significantly decreased with BMP4 inhibition. Yellow dotted and arrow showed area represent infiltrating area in the submandibular glands. h IFN-γ+ T cells in the submandibular glands from BMP4 BMMSCs injection inhibition were upregulated compared with BMMSCs injection group (n = 5, three independent experiments). Values are means ± SD. Student’s t tests and one-way ANOVA. *P ≤ 0.05; **P ≤ 0.01, scale bar: 200 μm.